Rosmarinic acid, a serious part of rosemary, is a polyphenolic compound with potential neuroprotective results. Asreducing the synaptic launch of glutamate is essential to reaching neuroprotectant’s pharmacotherapeutic results, the impact of rosmarinic acid on glutamate launch was investigated in rat cerebrocortical nerve terminals (synaptosomes). Rosmarinic acid depressed the 4-aminopyridine (4-AP)-induced glutamate launch in a concentration-dependent method. The removing of extracellular calcium and the blockade of vesicular transporters prevented the inhibition of glutamate launch by rosmarinic acid.
Rosmarinic acid decreased 4-AP-induced intrasynaptosomal Ca2+ elevation. The inhibition of N-, P/Q-type Ca2+ channels and the calcium/calmodulin-dependent kinase II (CaMKII) prevented rosmarinic acid from having results on glutamate launch. Rosmarinic acid additionally decreased the 4-AP-induced activation of CaMKII and the next phosphorylation of synapsin I, the primary presynaptic goal of CaMKII. As well as, immunocytochemistry confirmed the presence of GABAA receptors. GABAA receptor agonist and antagonist blocked the inhibitory impact of rosmarinic acid on 4-AP-evoked glutamate launch.
Docking knowledge additionally revealed that rosmarinic acid shaped a hydrogen bond with the amino acid residues of GABAA receptor. These outcomes instructed that rosmarinic acid prompts GABAA receptors in cerebrocortical synaptosomes to lower Ca2+ inflow and CaMKII/synapsin I pathway to inhibit the evoked glutamate launch.
Encapsulation of bioactive compounds from byproducts of two species of passionflowers: analysis of the physicochemical properties and managed launch in a gastrointestinal mannequin
This examine aimed to guage the discharge of energetic parts with antioxidant and antihypertensive capability from encapsulated extracts of the peel and seeds of Gulupa (Passiflora edulis f. edulis) and Cholupa (Passiflora maliformis) in an in vitro gastrointestinal digestion mannequin. Microencapsulated extracts have been ready with enzymatically modified rice starch because the encapsulating materials and ethanol extracts of seeds and peel of P. edulis f. edulis and P. maliformis as encapsulated materials. Microcapsule characterization was carried out by scanning electron microscopy with values of 4.54-5.13 μm and ξ potential values of -6.34 mV and -6.66 mV.
Dynamic gentle scattering (DLS) evaluation was performed with polydispersion values from 1.33 to 1.51, and dispersion stability evaluation was additionally performed. The overall phenol content material and antioxidant actions (ABTS, DPPH, and FRAP) and ACE inhibitory exercise (in vitro antihypertensive exercise) have been evaluated after every stage of digestion, with values higher than 80% of exercise earlier than gastrointestinal transit and with values higher than 55% exercise after the top of gastrointestinal transit. Gastrointestinal analysis of the encapsulated extracts was carried out with an ex vivo mannequin utilizing pig intestines and simulating the circumstances of digestion in three phases: the gastric (pH 2.Zero with 1.
Zero M HCl +0.5 g/L pepsin), enteric (pH 8.Zero with Krebs resolution +1.Zero mL/L bile) and last enteric (pH 7.5 Krebs resolution solely) phases. The microencapsulation of passionflower extracts confirmed good conduct in opposition to adjustments in pH and enzymatic actions all through digestion, thus selling a managed launch and focused supply of bioactive compounds, present process a paracellular mechanism by means of the intestinal barrier to protect the antioxidant exercise and ACE inhibitory that was proven by the extracts earlier than encapsulation of the fabric.
The impact of UV radiation on O-7 Actinomycete in producing bioactive compounds in numerous development circumstances
Actinomycetes have been recognized as an origin of many secondary metabolites, antibiotics and energetic parts that influence microbial development. Mediated mutations utilizing UV in follow for the breeding of organisms. The target of this examine is to analyses the influence of UV radiation on the (O-7) Actinomycete isolate. This was a potential analytical examine of a a number of of actinomycetes. The isolates have been screened for antimicrobial efficacy in opposition to a number of Gram-positive, Gram-negative micro organism, yeast, and fungi. Varied elements resembling UV, temperature, pH, gentle, agitation, fermentation durations and aeration have additionally been boosted for optimum antimicrobial manufacturing.
The isolate (O-7) Actinomycete has been acknowledged as a extremely bioactive producing organism. The isolate was uncovered to numerous wavelengths, instances underneath quite a few development circumstances. It was discovered that 4% focus of glucose as a carbon supply is considerably optimum for the manufacturing of antibiotic for (O-7) UV uncovered pressure, nonetheless, focus of 1% of lactose is considerably optimum for the manufacturing of antibiotic for (O-7) UV uncovered pressure. Yeast extract at a focus of 1% was discovered to be the very best supply of nitrogen for (O-7) UV uncovered, whereas pH 7.
Zero was discovered to be probably the most appropriate for a similar isolate. From the temperature optimization examine, it was noticed that (O-7) uncovered pressure confirmed good development and most antibiotic manufacturing at 28 °C. The soil-isolated organic compounds (O-7) have been efficient in opposition to sure sorts of micro organism and fungi, and the analysis additionally demonstrated that publicity to UV radiation enhanced the manufacturing of those compounds.Elucidating the switch of bioactive compounds between crops is important for understanding plant-plant interactions, growing pure pesticides and understanding their modes of motion. This text is protected by copyright. All rights reserved.
Translocation of metabolites between completely different plant species gives necessary hints in understanding the destiny of bioactive root exudates. Within the current examine, focused and untargeted mass spectrometry-based metabolomics was utilized to elucidate the switch of bioactive compounds between rye and a number of other crops and weed species. Our outcomes demonstrated that benzoxazinoids (BXs) synthesized by rye have been taken up by roots of neighbouring plant species and translocated into their shoots.
Gpat2 (untagged) - Rat glycerol-3-phosphate acyltransferase 2, mitochondrial (Gpat2) |
|||
| RN217218 | Origene Technologies GmbH | 10 µg | Ask for price |
Mouse GPAT2 shRNA Plasmid |
|||
| 20-abx980934 | Abbexa |
|
|
Human GPAT2 shRNA Plasmid |
|||
| 20-abx965673 | Abbexa |
|
|
GPAT2 Recombinant Protein (Rat) |
|||
| RP203177 | ABM | 100 ug | Ask for price |
GPAT2 Recombinant Protein (Human) |
|||
| RP060951 | ABM | 100 ug | Ask for price |
GPAT2 Recombinant Protein (Mouse) |
|||
| RP139238 | ABM | 100 ug | Ask for price |
Gpat2 ORF Vector (Rat) (pORF) |
|||
| ORF067727 | ABM | 1.0 ug DNA | EUR 607.2 |
Gpat2 (myc-DDK-tagged) - Rat glycerol-3-phosphate acyltransferase 2, mitochondrial (Gpat2) |
|||
| RR217218 | Origene Technologies GmbH | 10 µg | Ask for price |
GPAT2 ORF Vector (Human) (pORF) |
|||
| ORF020318 | ABM | 1.0 ug DNA | Ask for price |
Gpat2 ORF Vector (Mouse) (pORF) |
|||
| ORF046414 | ABM | 1.0 ug DNA | EUR 607.2 |
Human GPAT2 knockout cell line |
|||
| ABC-KH6266 | AcceGen | 1 vial | Ask for price |
|
Description: Human GPAT2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
Human GPAT2 knockdown cell line |
|||
| ABC-KD6266 | AcceGen | 1 vial | Ask for price |
|
Description: Human GPAT2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
Human GPAT2 Protein Lysate 20ug |
|||
| IHUGPAT2PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human GPAT2 Protein Lysate 20ug |
|||
OCOA03374-20UG - GPAT2 Protein Lysate |
|||
| OCOA03374-20UG | Aviva Systems Biology | 20ug | EUR 169 |
GPAT2 Over-expression Lysate Product |
|||
| GWB-623E08 | GenWay Biotech | 0.1 mg | Ask for price |
Gpat2 sgRNA CRISPR Lentivector set (Rat) |
|||
| K6080101 | ABM | 3 x 1.0 ug | EUR 406.8 |
Gpat2 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3673901 | ABM | 3 x 1.0 ug | EUR 406.8 |
GPAT2 sgRNA CRISPR Lentivector set (Human) |
|||
| K2772901 | ABM | 3 x 1.0 ug | EUR 406.8 |
GPAT2 3'UTR GFP Stable Cell Line |
|||
| TU059103 | ABM | 1.0 ml | EUR 2799.6 |
Gpat2 3'UTR GFP Stable Cell Line |
|||
| TU255284 | ABM | 1.0 ml | Ask for price |
Gpat2 3'UTR GFP Stable Cell Line |
|||
| TU158926 | ABM | 1.0 ml | Ask for price |
GPAT2 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV270908 | ABM | 500 ng | EUR 1399.2 |
GPAT2 Protein Vector (Rat) (pPB-C-His) |
|||
| PV270906 | ABM | 500 ng | EUR 1399.2 |
GPAT2 Protein Vector (Rat) (pPB-N-His) |
|||
| PV270907 | ABM | 500 ng | EUR 1399.2 |
GPAT2 Protein Vector (Rat) (pPM-C-His) |
|||
| PV270909 | ABM | 500 ng | EUR 1399.2 |
GPAT2 Protein Vector (Human) (pPM-C-HA) |
|||
| PV081271 | ABM | 500 ng | Ask for price |
GPAT2 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV185656 | ABM | 500 ng | EUR 1278 |
GPAT2 Protein Vector (Human) (pPB-C-His) |
|||
| PV081269 | ABM | 500 ng | Ask for price |
GPAT2 Protein Vector (Human) (pPB-N-His) |
|||
| PV081270 | ABM | 500 ng | Ask for price |
GPAT2 Protein Vector (Human) (pPM-C-His) |
|||
| PV081272 | ABM | 500 ng | Ask for price |
GPAT2 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV185654 | ABM | 500 ng | EUR 1278 |
GPAT2 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV185655 | ABM | 500 ng | EUR 1278 |
GPAT2 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV185657 | ABM | 500 ng | EUR 1278 |
Gpat2 3'UTR Luciferase Stable Cell Line |
|||
| TU205284 | ABM | 1.0 ml | Ask for price |
GPAT2 3'UTR Luciferase Stable Cell Line |
|||
| TU009103 | ABM | 1.0 ml | EUR 2799.6 |
Gpat2 3'UTR Luciferase Stable Cell Line |
|||
| TU108926 | ABM | 1.0 ml | Ask for price |
GPAT2 (untagged)-Human glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), nuclear gene encoding mitochondrial protein |
|||
| SC124729 | Origene Technologies GmbH | 10 µg | Ask for price |
Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K6080102 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K6080103 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K6080104 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3673902 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3673903 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3673904 | ABM | 1.0 ug DNA | EUR 184.8 |
GPAT2 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K2772902 | ABM | 1.0 ug DNA | EUR 184.8 |
GPAT2 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K2772903 | ABM | 1.0 ug DNA | EUR 184.8 |
GPAT2 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K2772904 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 (untagged) - Mouse glycerol-3-phosphate acyltransferase 2, mitochondrial (Gpat2), nuclear gene encoding mitochondrial protein, (10ug) |
|||
| MC221731 | Origene Technologies GmbH | 10 µg | Ask for price |
GPAT2 (GFP-tagged) - Human glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), nuclear gene encoding mitochondrial protein |
|||
| RG209885 | Origene Technologies GmbH | 10 µg | Ask for price |
AAP49213-100UG - GPAT2 Peptide - N-terminal region |
|||
| AAP49213-100UG | Aviva Systems Biology | 100ug | EUR 99 |
Gpat2 (GFP-tagged) - Mouse glycerol-3-phosphate acyltransferase 2 mitochondrial (Gpat2) nuclear gene encoding mitochondrial protein, (10ug) |
|||
| MG218359 | Origene Technologies GmbH | 10 µg | Ask for price |
Gpat2 (Myc-DDK-tagged) - Mouse glycerol-3-phosphate acyltransferase 2, mitochondrial (Gpat2), nuclear gene encoding mitochondrial protein |
|||
| MR218359 | Origene Technologies GmbH | 10 µg | Ask for price |
GPAT2 (Myc-DDK-tagged)-Human glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), nuclear gene encoding mitochondrial protein |
|||
| RC209885 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Gpat2 (GFP-tagged) - Mouse glycerol-3-phosphate acyltransferase 2, mitochondrial (Gpat2), nuclear gene encoding mitochondria |
|||
| MR218359L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, GPAT2 (mGFP-tagged) - Human glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), nuclear gene encoding mitochondri |
|||
| RC209885L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, GPAT2 (mGFP-tagged) - Human glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), nuclear gene encoding mitochondri |
|||
| RC209885L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, GPAT2 (Myc-DDK tagged) - Human glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), nuclear gene encoding mitochon |
|||
| RC209885L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, GPAT2 (Myc-DDK tagged) - Human glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), nuclear gene encoding mitochon |
|||
| RC209885L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Gpat2 (Myc-DDK-tagged) - Mouse glycerol-3-phosphate acyltransferase 2, mitochondrial (Gpat2), nuclear gene encoding mitochon |
|||
| MR218359L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Gpat2 (mGFP-tagged) - Mouse glycerol-3-phosphate acyltransferase 2, mitochondrial (Gpat2), nuclear gene encoding mitochondrial |
|||
| MR218359L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Gpat2 (Myc-DDK-tagged) - Mouse glycerol-3-phosphate acyltransferase 2, mitochondrial (Gpat2), nuclear gene encoding mitochondr |
|||
| MR218359L3 | Origene Technologies GmbH | 10 µg | Ask for price |
GPAT2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
| SR315749 | Origene Technologies GmbH | 2 nmol | Ask for price |
Gpat2 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
| SR420237 | Origene Technologies GmbH | 2 nmol | Ask for price |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K6080105 | ABM | 3 x 1.0 ug | EUR 451.2 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K3673905 | ABM | 3 x 1.0 ug | EUR 451.2 |
GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K2772905 | ABM | 3 x 1.0 ug | EUR 451.2 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K6080106 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K6080107 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K6080108 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K3673906 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K3673907 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K3673908 | ABM | 1.0 ug DNA | EUR 200.4 |
GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K2772906 | ABM | 1.0 ug DNA | EUR 200.4 |
GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K2772907 | ABM | 1.0 ug DNA | EUR 200.4 |
GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K2772908 | ABM | 1.0 ug DNA | EUR 200.4 |
GPAT2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL307972 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
Gpat2 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL517838 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
GPAT1 Antibody |
|||
| 24687 | SAB | 100ul | EUR 479 |
GPAT1 Antibody |
|||
| 24687-100ul | SAB | 100ul | EUR 468 |
GPAT1 Antibody |
|||
| 4613-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: GPAT1 Antibody: Glycerol-3-phosphate acyltransferase 1 (GPAT1), one of four known GPAT isoforms, is located on the mitochondrial outer membrane, allowing reciprocal regulation with carnitine palmitoyltransferase-1. It is thought to be critical for the development of hepatic steatosis; steatosis triggered by GPAT1 overexpression leads to hepatic and possibly peripheral insulin resistance. GPAT1 is transcriptionally upregulated by insulin and sterol regulatory element binding protein (SREBP-1) and downregulated by AMP-activated protein kinase. Mice deficient in GPAT1 exhibit decreased triacylglycerol (TAG) in cardiomyocytes even in high-fat diets, suggesting that GPAT1 contributes significantly to TAG accumulation in heart tissue during lipogenic or high fat diets. |
|||
GPAT1 Antibody |
|||
| 4613-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: GPAT1 Antibody: Glycerol-3-phosphate acyltransferase 1 (GPAT1), one of four known GPAT isoforms, is located on the mitochondrial outer membrane, allowing reciprocal regulation with carnitine palmitoyltransferase-1. It is thought to be critical for the development of hepatic steatosis; steatosis triggered by GPAT1 overexpression leads to hepatic and possibly peripheral insulin resistance. GPAT1 is transcriptionally upregulated by insulin and sterol regulatory element binding protein (SREBP-1) and downregulated by AMP-activated protein kinase. Mice deficient in GPAT1 exhibit decreased triacylglycerol (TAG) in cardiomyocytes even in high-fat diets, suggesting that GPAT1 contributes significantly to TAG accumulation in heart tissue during lipogenic or high fat diets. |
|||
GPAT4 Antibody |
|||
| DF14685 | Affbiotech | 100ul | EUR 420 |
GPAT4 Antibody |
|||
| DF14685-100ul | Affinity Biosciences | 100ul | EUR 280 |
GPAT4 Antibody |
|||
| DF14685-200ul | Affinity Biosciences | 200ul | EUR 350 |
GPAT4 Antibody |
|||
| E40PV7627 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
GPAT3 Antibody |
|||
| E40PV8655 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
GPAT-2 Antibody |
|||
| DF13583 | Affbiotech | 100ul | EUR 420 |
GPAT-2 Antibody |
|||
| DF13583-100ul | Affinity Biosciences | 100ul | EUR 280 |
GPAT-2 Antibody |
|||
| DF13583-200ul | Affinity Biosciences | 200ul | EUR 350 |
Human Glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2) ELISA Kit |
|||
| abx525898-96tests | Abbexa | 96 tests | EUR 687.5 |
Mouse Glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2) ELISA Kit |
|||
| abx525899-96tests | Abbexa | 96 tests | EUR 687.5 |
Gpat2 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vectorr |
|||
| TR517838 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
GPAT2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector |
|||
| TR307972 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
Polyclonal GPAT1 Antibody |
|||
| AMM05175G | Leading Biology | 0.1 mg | EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPAT1 . This antibody is tested and proven to work in the following applications: |
|||
OAAJ04194-100UL - GPAT3 Antibody |
|||
| OAAJ04194-100UL | Aviva Systems Biology | 100uL | EUR 319 |
Rabbit Polyclonal GPAT1 Antibody |
|||
| TA306579 | Origene Technologies GmbH | 100 µg | Ask for price |
ARP50103_P050-25UL - GPAT3 Antibody - middle region |
|||
| ARP50103_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP50104_P050-25UL - GPAT3 Antibody - middle region |
|||
| ARP50104_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP60802_P050-25UL - GPAT4 Antibody - middle region |
|||
| ARP60802_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
GPAT3 Rabbit Polyclonal Antibody |
|||
| E10G05029 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPAT4 Rabbit Polyclonal Antibody |
|||
| E10G05458 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPAT3 Rabbit Polyclonal Antibody |
|||
| E10G11917 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPAT4 Rabbit Polyclonal Antibody |
|||
| E10G12336 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPAT4 Rabbit Polyclonal Antibody |
|||
| E10G07799 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
OASG04276-100UL - GPAT3 Antibody - C-terminal region |
|||
| OASG04276-100UL | Aviva Systems Biology | 100ul | EUR 239 |
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| 20-abx211974 | Abbexa |
|
|
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| 20-abx212042 | Abbexa |
|
|
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| 20-abx212043 | Abbexa |
|
|
Glycerol-3-Phosphate Acyltransferase 3 (GPAT3) Antibody |
|||
| 20-abx329242 | Abbexa |
|
|
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| abx211974-100l | Abbexa | 100 µl | EUR 350 |
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| abx211974-50l | Abbexa | 50 µl | EUR 250 |
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| abx212042-100l | Abbexa | 100 µl | EUR 350 |
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| abx212042-50l | Abbexa | 50 µl | EUR 250 |
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| abx212043-100l | Abbexa | 100 µl | EUR 350 |
Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody |
|||
| abx212043-50l | Abbexa | 50 µl | EUR 250 |
Glycerol-3-Phosphate Acyltransferase 3 (GPAT3) Antibody |
|||
| abx329242-100l | Abbexa | 100 µl | EUR 187.5 |
GPAT4 (N-term) rabbit polyclonal antibody, Aff - Purified |
|||
| AP50113PU-N | Origene Technologies GmbH | 400 µl | Ask for price |
GPATCH8 Antibody |
|||
| 45984-100ul | SAB | 100ul | EUR 302.4 |
GPATCH8 Antibody |
|||
| 45984-50ul | SAB | 50ul | EUR 224.4 |
GPATCH8 Antibody |
|||
| DF9522 | Affbiotech | 200ul | EUR 420 |
GPATCH8 Antibody |
|||
| DF9522-100ul | Affinity Biosciences | 100ul | EUR 280 |
GPATCH8 Antibody |
|||
| DF9522-200ul | Affinity Biosciences | 200ul | EUR 350 |
GPATCH4 Antibody |
|||
| E40PV1635 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
GPATCH2 Antibody |
|||
| E311496 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
GPATCH8 Antibody |
|||
| E19-9522-1 | EnoGene | 50ug/50ul | EUR 145 |
|
Description: Available in various conjugation types. |
|||
GPATCH8 Antibody |
|||
| E19-9522-2 | EnoGene | 100ug/100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPATCH8 Antibody |
|||
| ABD9522 | Lifescience Market | 100 ug | EUR 525.6 |
GPATCH2L Antibody |
|||
| DF16064 | Affbiotech | 100ul | EUR 420 |
GPATCH2L Antibody |
|||
| DF16064-100ul | Affinity Biosciences | 100ul | EUR 280 |
GPATCH2L Antibody |
|||
| DF16064-200ul | Affinity Biosciences | 200ul | EUR 350 |
GPATCH2L Antibody |
|||
| E40PV921 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
anti- GPATCH2 antibody |
|||
| FNab03575 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against GPATCH2 |
|||
anti- GPATCH4 antibody |
|||
| FNab03576 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against GPATCH4 |
|||
GPATCH2 Polyclonal Antibody |
|||
| 29987 | SAB | 100ul | EUR 439 |
GPATCH2 Polyclonal Antibody |
|||
| 29987-100ul | SAB | 100ul | EUR 302.4 |
GPATCH2 Polyclonal Antibody |
|||
| 29987-50ul | SAB | 50ul | EUR 224.4 |
GPATCH2 Polyclonal Antibody |
|||
| E917175 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPATCH8 Conjugated Antibody |
|||
| C45984 | SAB | 100ul | EUR 476.4 |
GPATCH2 Polyclonal Antibody |
|||
| E-AB-91722-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
GPATCH2 Polyclonal Antibody |
|||
| E-AB-91722-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
GPATCH2 Polyclonal Antibody |
|||
| E-AB-91722-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
Moreover, we confirmed that roots of rye crops took up compounds originating from neighbouring crops. Among the many compounds taken up by rye roots, wogonin was detected within the rye shoot, which indicated a root-to-shoot translocation of this compound.